Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate that ingenol mebutate gel is efficacious in
treating Actinic Keratoses (AKs) present 8 weeks after initial field treatment or emerging in
a previously cleared field.